This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Abstract
Objective: The aim of this prospective study was to investigate the relationships between inflammation, cerebral vasoregulation, and cognitive decline in type 2 diabetes mellitus (T2DM) over a 2-year span.
Methods: Sixty-five participants (aged 66 ± 9.2 years, 35 with T2DM, 33 women) were enrolled for this 2-year prospective study. Continuous arterial spin labeling at 3-tesla MRI was used to measure global and regional cerebral perfusion and vasoreactivity. Neuropsychological measures were evaluated at the beginning and completion of the study. The associations between serum inflammatory markers, regional cerebral vasoreactivity, and cognitive functions were examined using least squares models.
Results: After 2 years of follow-up, participants with T2DM had diminished global and regional cerebral vasoreactivity and a decline in multiple cognitive tasks compared with baseline (p < 0.0001–0.012). In the T2DM group, lower cerebral vasoreactivity was associated with a greater decrease in daily living activities score (r2adj = 0.35, p = 0.04), and lower global vasodilation was associated with a greater decline in executive function (r2adj = 0.6, p = 0.047). Higher serum soluble intercellular and vascular adhesion molecules, higher cortisol, and higher C-reactive protein levels at baseline were associated with greater decreases in cerebral vasoreactivity and vasodilation only in the T2DM group (r2adj = 0.16–0.53, p = 0.007–0.048), independent of diabetes control and 24-hour blood pressure. Higher glycated hemoglobin A1c levels were associated with a greater increase in vasoconstriction in the T2DM group.
Conclusions: Inflammation may further impair cerebral vasoregulation, which consequently accelerates decline in executive function and daily activities performance in older people with T2DM.
GLOSSARY
- BMI=
- body mass index;
- BP=
- blood pressure;
- CASL=
- continuous arterial spin labeling;
- CRP=
- C-reactive protein;
- HbA1c=
- glycated hemoglobin A1c;
- Hct=
- hematocrit;
- HVLT-R=
- Hopkins Verbal Learning Test–Revised;
- IADL=
- Instrumental Activities of Daily Living;
- IL-6=
- interleukin 6;
- MAP=
- mean arterial pressure;
- MMSE=
- Mini-Mental State Examination;
- MP-RAGE=
- magnetization-prepared rapid-acquisition gradient echo;
- ROCF=
- Rey-Osterrieth Complex Figure;
- sICAM=
- soluble intercellular adhesion molecule;
- sVCAM=
- soluble vascular adhesion molecule;
- T2DM=
- type 2 diabetes mellitus;
- VF=
- Verbal Fluency
Footnotes
Go to Neurology.org for full disclosures. Funding information and disclosures deemed relevant by the authors, if any, are provided at the end of the article.
- Received December 19, 2014.
- Accepted in final form April 6, 2015.
- © 2015 American Academy of Neurology
AAN Members: Sign in with your AAN member credentials (e-mail or 6-digit Member ID number)
Non-AAN Member subscribers: Sign in with subscriber credentials
Log in using your username and password
Purchase access
Disputes & Debates: Rapid online correspondence
NOTE: All authors' disclosures must be entered and current in our database before comments can be posted. Enter and update disclosures at http://submit.neurology.org. Exception: replies to comments concerning an article you originally authored do not require updated disclosures.
- Stay timely. Submit only on articles published within the last 8 weeks.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- 200 words maximum.
- 5 references maximum. Reference 1 must be the article on which you are commenting.
- 5 authors maximum. Exception: replies can include all original authors of the article.
- Submitted comments are subject to editing and editor review prior to posting.